European Heart Journal Advance Access originally published online on June 26, 2008
European Heart Journal 2008 29(16):1930-1931; doi:10.1093/eurheartj/ehn304
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org
Biodegradable coating for drug-eluting stents—more than a facelift?
Heart Center, Tampere University Hospital, FI-33521 Tampere, Finland
* Corresponding author. Tel: +358 3 247 5111, Fax: +358 3 247 4157, Email: kari.niemela@pshp.fi
This editorial refers to Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis
by J. Mehilli et al., on page 1975
Footnotes
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
| The first 10% of the full text of this article appears below. |
Since its introduction 1977, percutaneous coronary angioplasty (PCI) has developed into the most common revascularization method of coronary artery disease (nearly 2 million procedures in Europe in 2003).1,2 Early complications of plain old balloon angioplasty such as acute recoil and abrupt vessel closure were markedly reduced by bare metal stents (BMS; in 1987) providing mechanical scaffolding of the vessel.3 Metallic stents thereby not only reduced the need for emergency coronary artery bypass grafting to <0.5% but nearly halved high restenosis rates
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis
- Julinda Mehilli, Robert A. Byrne, Anna Wieczorek, Raisuke Iijima, Stefanie Schulz, Olga Bruskina, Jürgen Pache, Rainer Wessely, Albert Schömig, Adnan Kastrati, and for the Intracoronary Stenting and Angiographic Restenosis Investigators – Test Efficacy of Rapamycin-eluting Stents with Different Polymer Coating Strategies (ISAR-TEST-3)
EHJ 2008 29: 1975-1982.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
R. A. Byrne, A. Kastrati, S. Kufner, S. Massberg, K. A. Birkmeier, K.-L. Laugwitz, S. Schulz, J. Pache, M. Fusaro, M. Seyfarth, et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial Eur. Heart J., October 2, 2009; 30(20): 2441 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A Byrne, S Kufner, K Tiroch, S Massberg, K-L Laugwitz, A Birkmeier, S Schulz, J Mehilli, and for the Intracoronary Stenting and Angiographic Re Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results Heart, September 15, 2009; 95(18): 1489 - 1494. [Abstract] [Full Text] [PDF] |
||||

